| Characterization of the gut microbiome using 16S or shotgun metagenomics J Jovel, J Patterson, W Wang, N Hotte, S O'Keefe, T Mitchel, T Perry, ... Frontiers in microbiology 7, 459, 2016 | 892 | 2016 |
| Fecal Microbiota Transplant for Treatment ofClostridium difficileInfection in Immunocompromised Patients CR Kelly, C Ihunnah, M Fischer, A Khoruts, C Surawicz, A Afzali, ... Official journal of the American College of Gastroenterology| ACG 109 (7 …, 2014 | 722 | 2014 |
| The human gut microbiome in health and disease J Jovel, LA Dieleman, D Kao, AL Mason, E Wine Metagenomics, 197-213, 2018 | 702 | 2018 |
| Effect of oral capsule–vs colonoscopy-delivered fecal microbiota transplantation on recurrent Clostridium difficile infection: a randomized clinical trial D Kao, B Roach, M Silva, P Beck, K Rioux, GG Kaplan, HJ Chang, ... Jama 318 (20), 1985-1993, 2017 | 598 | 2017 |
| International consensus conference on stool banking for faecal microbiota transplantation in clinical practice G Cammarota, G Ianiro, CR Kelly, BH Mullish, JR Allegretti, Z Kassam, ... Gut 68 (12), 2111-2121, 2019 | 377 | 2019 |
| Microbial bile salt hydrolases mediate the efficacy of faecal microbiota transplant in the treatment of recurrent Clostridioides difficile infection BH Mullish, JAK McDonald, A Pechlivanis, JR Allegretti, D Kao, GF Barker, ... Gut 68 (10), 1791-1800, 2019 | 215 | 2019 |
| Microbial bile salt hydrolases mediate the efficacy of faecal microbiota transplant in the treatment of recurrent Clostridioides difficile infection BH Mullish, JAK McDonald, A Pechlivanis, JR Allegretti, D Kao, GF Barker, ... Gut 68 (10), 1791-1800, 2019 | 215 | 2019 |
| Fecal Microbial Transplants Reduce Antibiotic-resistant Genes in Patients With Recurrent Clostridium difficile Infection B Millan, H Park, N Hotte, O Mathieu, P Burguiere, TA Tompkins, D Kao, ... Clinical infectious diseases 62 (12), 1479-1486, 2016 | 213 | 2016 |
| The long-term efficacy and safety of fecal microbiota transplant for recurrent, severe, and complicated Clostridium difficile infection in 146 elderly individuals M Agrawal, OC Aroniadis, LJ Brandt, C Kelly, S Freeman, C Surawicz, ... Journal of clinical gastroenterology 50 (5), 403-407, 2016 | 196 | 2016 |
| Bezlotoxumab for Prevention of Recurrent Clostridium difficile Infection in Patients at Increased Risk for Recurrence DN Gerding, CP Kelly, G Rahav, C Lee, ER Dubberke, PN Kumar, ... Clinical infectious diseases 67 (5), 649-656, 2018 | 188 | 2018 |
| Fecal Microbiota Transplantation is Safe and Efficacious for Recurrent or Refractory Clostridium difficile Infection in Patients with Inflammatory Bowel Disease M Fischer, D Kao, C Kelly, A Kuchipudi, SM Jafri, M Blumenkehl, D Rex, ... Inflammatory bowel diseases 22 (10), 2402-2409, 2016 | 176 | 2016 |
| Inhibiting growth of Clostridioides difficile by restoring valerate, produced by the intestinal microbiota JAK McDonald, BH Mullish, A Pechlivanis, Z Liu, J Brignardello, D Kao, ... Gastroenterology 155 (5), 1495-1507. e15, 2018 | 156 | 2018 |
| Fecal microbial transplantation and fiber supplementation in patients with severe obesity and metabolic syndrome: a randomized double-blind, placebo-controlled phase 2 trial V Mocanu, Z Zhang, EC Deehan, DH Kao, N Hotte, S Karmali, DW Birch, ... Nature Medicine 27 (7), 1272-1279, 2021 | 150 | 2021 |
| Fecal microbiota transplantation in the management of hepatic encephalopathy D Kao, B Roach, H Park, N Hotte, K Madsen, V Bain, P Tandon Hepatology 63 (1), 339-340, 2016 | 150 | 2016 |
| Managing the post–liver transplantation anastomotic biliary stricture: multiple plastic versus metal stents: a systematic review D Kao, S Zepeda-Gomez, P Tandon, VG Bain Gastrointestinal endoscopy 77 (5), 679-691, 2013 | 145 | 2013 |
| Predictors of early failure after fecal microbiota transplantation for the therapy of Clostridium difficile infection: a multicenter study M Fischer, D Kao, SR Mehta, T Martin, J Dimitry, AH Keshteli, GK Cook, ... Official journal of the American College of Gastroenterology| ACG 111 (7 …, 2016 | 142 | 2016 |
| Reorganisation of faecal microbiota transplant services during the COVID-19 pandemic G Ianiro, BH Mullish, CR Kelly, Z Kassam, EJ Kuijper, SC Ng, TH Iqbal, ... Gut 69 (9), 1555-1563, 2020 | 140 | 2020 |
| Fecal microbiota transplantation inducing remission in Crohn’s colitis and the associated changes in fecal microbial profile D Kao, N Hotte, P Gillevet, K Madsen Journal of clinical gastroenterology 48 (7), 625-628, 2014 | 132 | 2014 |
| Risk of bacterial infection in patients with cirrhosis and acute variceal hemorrhage, based on Child–Pugh class, and effects of antibiotics P Tandon, JG Abraldes, A Keough, R Bastiampillai, S Jayakumar, ... Clinical Gastroenterology and Hepatology 13 (6), 1189-1196. e2, 2015 | 126 | 2015 |
| Fecal microbiota transplantation for the treatment of recurrent and severe Clostridium difficile infection in solid organ transplant recipients: a multicenter experience YW Cheng, E Phelps, V Ganapini, N Khan, F Ouyang, H Xu, S Khanna, ... American journal of transplantation 19 (2), 501-511, 2019 | 115 | 2019 |
